164 related articles for article (PubMed ID: 36273446)
1. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
[TBL] [Abstract][Full Text] [Related]
2. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
[TBL] [Abstract][Full Text] [Related]
3. Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma.
Sakai M; Sohda M; Miyazaki T; Suzuki S; Sano A; Tanaka N; Inose T; Nakajima M; Kato H; Kuwano H
Anticancer Res; 2010 Mar; 30(3):851-6. PubMed ID: 20393006
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.
Zhou LN; Tan Y; Li P; Zeng P; Chen MB; Tian Y; Zhu YQ
Oncotarget; 2017 Jan; 8(1):303-314. PubMed ID: 27974678
[TBL] [Abstract][Full Text] [Related]
5. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.
Li C; Ji L; Ding ZY; Zhang QD; Huang GR
Tumour Biol; 2013 Apr; 34(2):1021-6. PubMed ID: 23283818
[TBL] [Abstract][Full Text] [Related]
7. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
[TBL] [Abstract][Full Text] [Related]
8. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.
Tsai MM; Huang HW; Wang CS; Lee KF; Tsai CY; Lu PH; Chi HC; Lin YH; Kuo LM; Lin KH
Oncotarget; 2016 Jun; 7(26):39511-39526. PubMed ID: 27078844
[TBL] [Abstract][Full Text] [Related]
10. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
[TBL] [Abstract][Full Text] [Related]
11. Importin KPNA2 confers HIV-1 pre-integration complex nuclear import by interacting with the capsid protein.
Song Y; Zhang H; Wang Y; Guo J; Tang S; Wang L; Peng K; Dong CS
Antiviral Res; 2022 Apr; 200():105289. PubMed ID: 35301060
[TBL] [Abstract][Full Text] [Related]
12. Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.
Drucker E; Holzer K; Pusch S; Winkler J; Calvisi DF; Eiteneuer E; Herpel E; Goeppert B; Roessler S; Ori A; Schirmacher P; Breuhahn K; Singer S
Cell Commun Signal; 2019 Nov; 17(1):159. PubMed ID: 31783876
[TBL] [Abstract][Full Text] [Related]
13. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
[TBL] [Abstract][Full Text] [Related]
14. KPNB1, XPO7 and IPO8 mediate the translocation ofNF-κB/p65 into the nucleus.
Liang P; Zhang H; Wang G; Li S; Cong S; Luo Y; Zhang B
Traffic; 2013 Nov; 14(11):1132-43. PubMed ID: 23906023
[TBL] [Abstract][Full Text] [Related]
15. KPNA2 over-expression is a potential marker of prognosis and therapeutic sensitivity in colorectal cancer patients.
Takada T; Tsutsumi S; Takahashi R; Ohsone K; Tatsuki H; Suto T; Kato T; Fujii T; Yokobori T; Kuwano H
J Surg Oncol; 2016 Feb; 113(2):213-7. PubMed ID: 26663089
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma.
Hu ZY; Yuan SX; Yang Y; Zhou WP; Jiang H
J Exp Clin Cancer Res; 2014 Jul; 33(1):61. PubMed ID: 25060425
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
Cui X; Wang H; Wu X; Huo K; Jing X
J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
[TBL] [Abstract][Full Text] [Related]
19. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
Zhang Y; Li KF
Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
[TBL] [Abstract][Full Text] [Related]
20. The emerging roles of KPNA2 in cancer.
Han Y; Wang X
Life Sci; 2020 Jan; 241():117140. PubMed ID: 31812670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
